{
  "id": "o-rads-mri-df9410",
  "title": "O-RADS MRI",
  "source": "o-rads-mri.html",
  "blocks": [
    {
      "type": "heading",
      "level": 2,
      "text": "Essentials"
    },
    {
      "type": "paragraph",
      "text": "Source: ACR O-RADS MRI Risk Score Assessment and Management (PDF)."
    },
    {
      "type": "list",
      "items": [
        "Applies to adnexal (ovarian/tubal) masses in non-pregnant patients; score 1-5 reflects malignancy risk and guides management.",
        "Score is driven by morphology, presence and behavior of enhancing solid tissue, DWI signal, and time-intensity curve (TIC) relative to outer myometrium.",
        "Typical benign descriptors (score 2) override higher scores; physiologic findings are score 1.",
        "DWI: high if solid tissue signal is > endometrium on high b-value (>=800) and shows low ADC; low if <= myometrium with no ADC restriction.",
        "TIC (solid tissue vs outer myometrium): Type 1 progressive; Type 2 plateau; Type 3 washout (faster than myometrium).",
        "Solid tissue includes papillary projections, mural nodules, septations >=3 mm that enhance, or other enhancing soft tissue components."
      ]
    },
    {
      "type": "heading",
      "level": 2,
      "text": "O-RADS MRI Risk Score"
    },
    {
      "type": "paragraph",
      "text": "Risk categories, PPV bands, and management."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Classic Benign Lesions (Score 2)"
    },
    {
      "type": "paragraph",
      "text": "If present, classify as score 2 regardless of TIC/DWI."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Solid Tissue Decision Guide"
    },
    {
      "type": "paragraph",
      "text": "Assign score for masses with enhancing solid tissue (papillae, mural nodules, septa >=3 mm)."
    },
    {
      "type": "paragraph",
      "text": "TIC reference: compare to outer myometrium. High DWI: b>=800 signal > endometrium with corresponding low ADC. Low DWI: <= myometrium and no low ADC. Solid tissue includes papillary projections, mural nodules, septa >=3 mm, or other enhancing components."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Management by Score"
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Quick Workflow"
    },
    {
      "type": "paragraph",
      "text": "Use morphology to capture classic benign lesions; otherwise score solid tissue with TIC and DWI, then manage per O-RADS MRI 1-5."
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Reporting Tips"
    },
    {
      "type": "list",
      "items": [
        "Describe lesion type (cystic, multilocular, solid), solid tissue components, TIC type, and DWI/ADC behavior.",
        "State O-RADS MRI score and rationale (classic benign descriptor, TIC/DWI combination, or ancillary malignant features).",
        "Recommend management per score and note if gynecologic oncology consultation is advised (scores 4-5)."
      ]
    },
    {
      "type": "heading",
      "level": 2,
      "text": "Source"
    },
    {
      "type": "paragraph",
      "text": "ACR O-RADS MRI Risk Score Assessment and Management. PDF: link."
    }
  ]
}
